Merck KGaA (MKKGY) News Today $26.33 +0.45 (+1.74%) As of 03:55 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock MKKGY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Merck KGaA (OTCMKTS:MKKGY) Stock Rating Lowered by BarclaysAugust 22 at 10:13 AM | marketbeat.comMerck shares snapped six-session winning streakAugust 20 at 5:09 PM | msn.comMerck KGaA (OTCMKTS:MKKGY) Shares Gap Down - Time to Sell?August 20 at 1:22 PM | marketbeat.comMerck KGaA Signs $2 Billion Neurology Drug Pact With SkyhawkAugust 18, 2025 | bloomberg.comTata, Merck explore exclusive chemical deal for Dholera semiconductor facilityAugust 15, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Posts Quarterly Earnings ResultsAugust 10, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKKGY) Sees Strong Trading Volume After Strong EarningsAugust 10, 2025 | marketbeat.comIs Wall Street Bullish or Bearish on Merck Stock?August 4, 2025 | finance.yahoo.comN.J.-based Merck announces $3B in cost cutting measures including layoffsJuly 31, 2025 | msn.comMerck KGaA (MKKGY) Expected to Announce Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comJefferies Raises Merck (MRK) Price Target, Maintains Buy RatingJuly 18, 2025 | msn.comBristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancerJuly 18, 2025 | msn.comVerona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters SentimentJuly 17, 2025 | msn.comEurope is lagging behind in AI-specific patents: Merck KGaAJuly 16, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Shares Gap Down - Should You Sell?July 14, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKKGY) Shares Up 0.2% - Here's What HappenedJuly 10, 2025 | marketbeat.comPharma Giant Merck Buys Lung Therapy Firm Verona For $10 BillionJuly 9, 2025 | baystreet.caVerona Pharma shares jump with Merck set to acquire company in $10 billion dealJuly 9, 2025 | msn.comKennedy's US Vaccine Panel Votes in Favor of Merck's RSV Antibody DrugJune 26, 2025 | usnews.comMerck KGaA (OTCMKTS:MKKGY) Sees Significant Drop in Short InterestJune 18, 2025 | marketbeat.comBenchling and Merck collaborate on vaccine bioanalysisJune 15, 2025 | msn.comThe Motley Fool: Merck’s risks and potentialJune 15, 2025 | dallasnews.comDMerck Gets FDA Approval for Respiratory Treatment for InfantsJune 10, 2025 | marketwatch.comMerck Says It Wins US Approval for Shot to Prevent Infant RSVJune 10, 2025 | bloomberg.comChina's Center for Drug Evaluation Accepts Merck's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comChina's Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comMerck KGaA (OTCMKTS:MKKGY) Short Interest Up 38.7% in MayJune 2, 2025 | marketbeat.comMerck, Daiichi Sankyo Withdraw Application Seeking FDA Nod for ADCMay 29, 2025 | marketwatch.comMerck KGaA Shares Slide After Outlook Cut on Tariff, Currency RisksMay 16, 2025 | wsj.comMerck KGaA (MKKGY) Expected to Announce Earnings on WednesdayMay 16, 2025 | marketbeat.comMerck says late-stage trial for Keytruda regimen hit main goal in ovarian cancerMay 15, 2025 | msn.comMerck KGaA shares down after lowered 2025 outlook overshadows mixed Q1 resultsMay 15, 2025 | investing.comMerck KGaA: Strategic Growth Amidst Challenges Supports Buy RatingMay 15, 2025 | tipranks.comMerck KGaA Non-GAAP EPS of €2.12, revenue of €5.28B; updates FY25 outlookMay 15, 2025 | seekingalpha.comMerck KGaA (MKGAF) Reports Q1 Earnings and Revenue GrowthMay 15, 2025 | gurufocus.comGermany's Merck drops China surcharge on orders after US-China tariff dealMay 14, 2025 | reuters.comGermany's Merck Expected to Post Higher Sales, Earnings -- Earnings PreviewMay 13, 2025 | marketwatch.comMerck’s $895M expansion is latest in wave of western Johnson County developmentsMay 9, 2025 | msn.comMerck Animal Health will spend $895M on 200-job expansion in De SotoMay 9, 2025 | bizjournals.comMerck Foundation CEO Congratulates Tanzania President on Being Awarded as 'Mother of the Nation Order' by the President of the United Arab EmiratesMay 6, 2025 | msn.comMerck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 BillionMay 4, 2025 | gurufocus.comAre Investors Undervaluing Merck KGaA (MKKGY) Right Now?May 1, 2025 | msn.comMerck KGaA (OTCMKTS:MKKGY) Short Interest UpdateMay 1, 2025 | marketbeat.comMerck to invest $1 billion in new Delaware plant to boost US manufacturingApril 29, 2025 | msn.comMerck breaks ground on $1B Delaware site to boost US supply chainApril 29, 2025 | msn.comSpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEOApril 29, 2025 | seekingalpha.comHold Rating on Merck KGaA’s Acquisition of Springworks: Strategic Fit with Valuation ConcernsApril 28, 2025 | tipranks.comMerck KGaA strikes $3.9bn deal for SpringWorksApril 28, 2025 | finance.yahoo.comTemu, Tesla prices, Merck KGaA deal: Trending TickersApril 28, 2025 | finance.yahoo.comMerck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 BillionApril 28, 2025 | gurufocus.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Email Address MKKGY Media Mentions By Week MKKGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKKGY News Sentiment▼0.070.62▲Average Medical News Sentiment MKKGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKKGY Articles This Week▼64▲MKKGY Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zoetis News Today Takeda Pharmaceutical News Today Daiichi Sankyo News Today BeOne Medicines News Today Sandoz Group News Today Summit Therapeutics News Today Shionogi & Co., Ltd. Unsponsored ADR News Today United Therapeutics News Today Neurocrine Biosciences News Today Orion OYJ News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKKGY) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access